Year: 2024
Type: article
Abstract: Since the outbreak of the COVID-19 pandemic caused by the SARS-CoV-2 virus, there has been a pressing need for effective and accessible antiviral agents. Aminocaproic acid (Epsilon-aminocaproic acid, EACA), known primarily for its antifibrinolytic properties, has recently been in the spotlight for its potential cytotoxic and antiviral capabilities. This study aims to evaluate the in vitro cytotoxicity and antiviral activity of EACA against SARS-CoV-2.An in-depth in vitro analysis was conducted i
DOI: 10.51847/uespvwavbt
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4400624521
